Inovio Pharmaceuticals (FRA:GBM) Long-Term Debt : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Inovio Pharmaceuticals Long-Term Debt?

Inovio Pharmaceuticals's Long-Term Debt for the quarter that ended in Mar. 2024 was €0.00 Mil.

Inovio Pharmaceuticals's annual Long-Term Debt increased from Dec. 2021 (€13.24 Mil) to Dec. 2022 (€15.69 Mil) but then declined from Dec. 2022 (€15.69 Mil) to Dec. 2023 (€0.00 Mil).

Inovio Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Inovio Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals Long-Term Debt Chart

Inovio Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

69.32

15.34

13.24

15.69

Inovio Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Inovio Pharmaceuticals (FRA:GBM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Inovio Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Inovio Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Inovio Pharmaceuticals (FRA:GBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (FRA:GBM) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

INO:USA INO:Mexico

Address

660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462

Website

https://www.inovio.com

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals (FRA:GBM) Headlines

No Headlines